基于MRI的影像组学预测前列腺癌生化复发:系统综述与荟萃分析
本系统综述与荟萃分析纳入24项研究(其中14项进入荟萃分析),评估基于MRI影像组学的机器学习模型预测前列腺癌治疗后生化复化的准确性。影像组学模型汇总AUC为0.75、敏感度72%、特异度78%,临床-影像组学联合模型汇总AUC最高达0.88、敏感度85%、特异度79%。作者认为MRI影像组学有预测潜力,但尚远未广泛临床应用,需进一步标准化和方法学改进。
要点
- 临床-影像组学联合模型汇总AUC 0.88、敏感度85%、特异度79%,优于单纯影像组学模型(AUC 0.75)。
- QUADAS-2显示方法学偏倚显著,尤其在索引试验及流程与时机领域。
- METRICS平均分65.68%(范围43.8%–82.2%),总体质量良好但部分领域存在方法学缺口。
核心结论
- MRI影像组学在预测前列腺癌生化复发方面显示出潜力,尤其与临床变量联合时。
- 该技术仍远未广泛用于临床,需要进一步标准化和关键方法学改进以提升泛化性和稳健性。
- 未来研究应采用多中心设计并进行充分外部验证,以增强在不同患者人群中的适用性。
研究设计与样本
- 系统综述与荟萃分析,检索PubMed、Scopus、Embase、Web of Science和IEEE五个数据库截至2024年12月23日的文献。
- 系统综述纳入24项开发基于MRI影像组学特征机器学习模型预测前列腺癌生化复发的研究,其中14项进入荟萃分析。
- 采用QUADAS-2和METRICS工具评估研究质量,采用双变量随机效应模型汇总验证队列中影像组学、临床及临床-影像组学模型的敏感度、特异度和AUC。
诊断标准与关键数值
- 影像组学机器学习模型汇总AUC 0.75、敏感度72%、特异度78%。
- 临床-影像组学模型汇总AUC 0.88、敏感度85%、特异度79%,为表现最高者。
- QUADAS-2显示方法学偏倚显著,尤其在索引试验及流程与时机领域。
- METRICS平均分65.68%,范围43.8%至82.2%。
临床应用与阅片要点
- 作者认为MRI影像组学在预测前列腺癌治疗后生化复发方面有潜力,尤其与临床变量联合时,但尚远未广泛临床应用。
局限性
- QUADAS-2显示方法学偏倚显著,尤其在索引试验及流程与时机领域。
- METRICS平均分65.68%(范围43.8%至82.2%),部分领域存在方法学缺口。
- 作者指出该技术仍远未广泛临床应用,需要进一步标准化和关键方法学改进以提升泛化性和稳健性。
- 作者建议未来研究采用多中心设计并进行充分外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Biochemical recurrence (BCR) following prostate cancer (PCa) treatment is a significant indicator of metastasis and mortality. Early prediction of BCR can guide treatment decisions, and optimize patient management strategies. MRI is essential for the diagnosis and surveillance of PCa. This study aimed to assess the accuracy and quality of MRI radiomics-based machine learning (ML) models for predicting post-treatment BCR in PCa.
METHODS: A systematic literature search was conducted across five electronic databases (PubMed, Scopus, Embase, Web of Science, and IEEE) up to December 23, 2024, to identify studies developing ML models based on MRI-derived radiomics features for the prediction of BCR in PCa. Studies were assessed for quality using the QUADAS-2 and METRICS tools. A meta-analysis of radiomics, clinical, and clinical-radiomics models in validation cohorts was performed to pool sensitivity, specificity, and area under the curve (AUC) using a bivariate random-effects model.
RESULTS: A total of 24 studies were incorporated into the systematic review, with 14 included in the meta-analysis. The pooled AUC, sensitivity, and specificity for radiomics-based ML models were 0.75, 72%, and 78%, respectively. Clinical-radiomics models showed the highest performance with a pooled AUC of 0.88, sensitivity of 85%, and specificity of 79%. QUADAS-2 revealed significant methodological biases, particularly in the index test and flow and timing domains. The mean METRICS score across studies was 65.68%, ranging from 43.8 to 82.2%, showing overall good quality but highlighting methodological gaps in some domains.
CONCLUSION: MRI-based radiomics demonstrates potential for predicting BCR in PCa, especially when integrated with clinical variables. However, it is still far from widespread clinical use, necessitating further standardization and key methodological improvements for better generalizability and robustness. Future studies should adopt multi-center designs and conduct thorough external validation to enhance applicability across diverse patient populations.
引用
- Salimi M, Vadipour P, Houshi S, et al. MRI-based radiomics for prediction of biochemical recurrence in prostate cancer: a systematic review and meta-analysis. Abdom Radiol (NY). 2025. PMID: 40146313. doi:10.1007/s00261-025-04892-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。